ENO2 and neoplasm: To assist the diagnosis of the mass, a panel of tumor biomarkers, including CEA (carcino-embryonic antigen), NSE (neuron-specific enolase), SCC (squamous cell carcinoma), and CYFRA21-1 (cytokeratin 19 fragments), were tested.